✦ LIBER ✦

Clinical Trial to Investigate the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Recombinant Factor VIIa in Japanese Patients With Hemophilia With Inhibitors

✍ Scribed by Akira Shirahata; Tadashi Kamiya; Junki Takamatsu; Tetsuhito Kojima; Katsuyuki Fukutake; Morio Arai; Hideji Hanabusa; Hisamichi Tagami; Akira Yoshioka; Midori Shima; Hiroyuki Naka; Shigeru Fujita; Yoko Minamoto; Junji Kamizono; Hidehiko Saito

Publisher: Carden Jennings Publishing
Year: 2001
Tongue: English
Weight: 98 KB
Volume: 73
Category: Article
ISSN: 0925-5710
DOI: 10.1007/bf02994016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful use of recombinant factor VII

Successful use of recombinant factor VIIa for emergency fasciotomy in a patient with hemophilia A and high-titer inhibitor unresponsive to factor VIII inhibitor bypassing activity

✍ Raymond G. Watts 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 2 views

A multicenter, randomized, double-blind

A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: Results of a phase III clinical trial

✍ Daniel L. Rubin; Terry S. Desser; Richard Semelka; Jeffrey Brown; Hanh V. Nghiem 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 3 views

Safety and efficacy of ocrelizumab in pa

Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: Results of a forty-eight–week randomized, double-blind, placebo-controlled, parallel-group phase III trial

✍ P. P. Tak; P. J. Mease; M. C. Genovese; J. Kremer; B. Haraoui; Y. Tanaka; C. O. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views